February 06, 2009 // Franchising.com // Highlands Ranch, Colo. –– Fitness Together Franchise Corporation has launched a national brand marketing campaign, giving the franchise network a new image and bold tools to communicate with high-end consumers who want to meet and exceed their fitness goals and live a healthier life.
“This campaign truly sets us apart from the fitness competition and speaks to what makes us different, unique and Read the rest of this entry »
BOSTON (MarketWatch) — The Food and Drug Administration said Tuesday that it has issued official warning letters to German drugmaker Bayer AG over the marketing of two aspirin products, Bayer Women’s and Bayer Heart Advantage. According to the agency, because the aspirin products are new formulations, the drugs cannot be legally marketed in the U.S. until they go through the drug approval process. Bayer Women’s contains calcium while Bayer Heart Read the rest of this entry »
A Justice Department inquiry into Stryker’s marketing of human bone growth products has resulted in guilty pleas by former company sales representatives.
One former sales official pleaded guilty two weeks ago, and another one did in November, court documents show.
Stryker, a leading maker of medical devices, and the United States attorney’s office in Boston, which is conducting the inquiry, declined to comment. A spokeswoman for Read the rest of this entry »
Hagens Berman Sobol Shapiro is based in Seattle with offices in Chicago,
Cambridge, Los Angeles, Phoenix, San Francisco and New York. Since 1993,
it has developed a nationally recognized practice in class-action and
complex litigation.Among recent successes, HBSS has negotiated a $300
million settlement in the DRAM memory antitrust litigation; a $340
million recovery on behalf of Enron employees; a $150 million Read the rest of this entry »
ClubCom is the world’s leading provider of
customized digital media networks for the fitness and bowling
industries. ClubCom operates over 1,600 venues comprising of over 25,000
screens and 60 million monthly viewers. ClubCom provides a comprehensive
suite of digital media services including overhead audio and video
entertainment, digital signage and personal viewing programming. ClubCom’s
networks have Read the rest of this entry »
LabCorp Illegally Marketing Ovarian Cancer Test Without FDA Approval, Agency Says
informing the company that it is illegally marketing a blood test to detect ovarian cancer in its early stages without agency approval, the
reports. The $220 test, called OvaSure, was released in June under a rule that exempts tests from FDA regulation that are developed and marketed by a single company. However, because the ovarian cancer test was developed at Read the rest of this entry »
TUESDAY, Oct. 28 (HealthDay News) — Drug giant Bayer HealthCare is illegally marketing two unapproved over-the-counter aspirin medications, the U.S. Food and Drug Administration said in warning letters issued Tuesday.
The products — Bayer Women’s Low Dose Aspirin + Calcium and Bayer Aspirin with Heart Advantage — are unapproved new drugs that require an approved new drug application to be legally marketed, the FDA said. In addition to being Read the rest of this entry »
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the U.S.
Food and Drug Administration (FDA) has granted marketing approval for
APRISO
(mesalamine) extended-release capsules
0.375 g. APRISO is a locally-acting aminosalicylate indicated for the
maintenance of remission of ulcerative colitis (UC) in adults. APRISO is
the first and only mesalamine product approved by the FDA for once-a-day
dosing for the maintenance of remission of ulcerative Read the rest of this entry »
Pfizer and Eli Lilly, both of which now have drugs approved to treat fibromyalgia, are spending heavily on marketing to raise awareness of the disorder, whose very existence is debated in medical circles.
before, fibromyalgia is controversial. Despite being recognized as a disease by the FDA and insurers, the pain that marks the condition tends to be long-standing and vague. The cause is unknown, and there’s no lab test to guide diagnosis. Read the rest of this entry »
from marketing its Medicare health plans and from enrolling new members in the plans.
and Medicare prescription drug plans. In a letter sent Thursday to WellCare, CMS said WellCare fell short in its enrollment and disenrollment operations, appeals and grievances, timely and proper responses to beneficiary complaints and requests for assistance, and marketing and agent/broker oversight activities.
In a statement issued Friday morning, WellCare Read the rest of this entry »